Allied ALID Stock
Allied Price Chart
Allied ALID Financial and Trading Overview
Allied stock price | 0.02 USD |
Previous Close | 0.26 USD |
Open | 0.2 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.2 - 0.28 USD |
52 Week Range | 0.1 - 0.7 USD |
Volume | 3.06K USD |
Avg. Volume | 8.43K USD |
Market Cap | 23.31M USD |
Beta (5Y Monthly) | 0.039961 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.04 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ALID Valuation Measures
Enterprise Value | 30.72M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 121.005 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 159.452 |
Enterprise Value/EBITDA | -5.688 |
Trading Information
Allied Stock Price History
Beta (5Y Monthly) | 0.039961 |
52-Week Change | -45.39% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.7 USD |
52 Week Low | 0.1 USD |
50-Day Moving Average | 0.24 USD |
200-Day Moving Average | 0.3 USD |
ALID Share Statistics
Avg. Volume (3 month) | 8.43K USD |
Avg. Daily Volume (10-Days) | 2.97K USD |
Shares Outstanding | 97.04M |
Float | 61.24M |
Short Ratio | N/A |
% Held by Insiders | 53.29% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 6.666:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | August 31, 2022 |
Most Recent Quarter (mrq) | February 28, 2023 |
Next Fiscal Year End | August 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -2827.43% |
Gross Margin | 303.10% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -58.10% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 192.67K USD |
Revenue Per Share (ttm) | 0.002 USD |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | 74.12K USD |
EBITDA | -5401205 USD |
Net Income Avi to Common (ttm) | -6519405 USD |
Diluted EPS (ttm) | -0.07 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 164.94K USD |
Total Cash Per Share (mrq) | 0.002 USD |
Total Debt (mrq) | 5.67M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.212 |
Book Value Per Share (mrq) | -0.021 |
Cash Flow Statement
Operating Cash Flow (ttm) | -3559635 USD |
Levered Free Cash Flow (ttm) | -2528659 USD |
Profile of Allied
Country | United States |
State | BC |
City | Kelowna |
Address | 1405 St. Paul Street |
ZIP | V1Y 9N2 |
Phone | N/A |
Website | https://allied.health |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Allied Corp., a medical cannabis production company, engages in the research, development, and production of cannabinoid health solutions in the United States. It offers hemp derived CBD natural health products, including Liberty, a hemp-derived cannabidiol (CBD) tincture; Tactical Hydration, a CBD infused electrolyte replacement drink; FIZZ Tablets for adding in a water bottle; Battle Balm, a CBD roll on activity rub for aches and pains; and Quick Hit, a CBD gummies under the Tactical Relief brand. The company also provides Hydrosport CBD Drink, a CBD infused electrolyte replacement drink with sodium citrate electrolyte replacement; Hydrosport Tincture, a CBD tincture fortified with specific terpene profile; FIZZ Tablets for adding to a water bottle; Sport Rub, a CBD post activity rub for aches and pains; and Quick Hit, a CBD gummies with vitamin B12 under the Equilibrium Bio brand. In addition, it offers Skin Structure, a facial formula topically applied to enhance skin's radiance and youthfulness; Eye Recover that helps the eye skin ward off free radicals, as well as helping to protect against sun damage; Glossy Lip Recover, which moisturizes and nourishes lips; Skin Designer that stimulates cell regeneration while minimizing age spots; Vitamin Absolute, a moisturizing facial oil; and Absolute Recover, a formulation that allows the infused bioactive compounds to be delivered directly to the desired areas of inflammation, pain, and other skin ailments under the MaXXa brand. In addition, it is developing ALID 10 and ALID 11, a pharma product, which is in Phase I clinical trial for treating post-traumatic stress disorder. The company was incorporated in 2013 and is headquartered in Kelowna, Canada.
Q&A For Allied Stock
What is a current ALID stock price?
Allied ALID stock price today per share is 0.02 USD.
How to purchase Allied stock?
You can buy ALID shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Allied?
The stock symbol or ticker of Allied is ALID.
Which industry does the Allied company belong to?
The Allied industry is Drug Manufacturers-Specialty & Generic.
How many shares does Allied have in circulation?
The max supply of Allied shares is 115.49M.
What is Allied Price to Earnings Ratio (PE Ratio)?
Allied PE Ratio is now.
What was Allied earnings per share over the trailing 12 months (TTM)?
Allied EPS is -0.04 USD over the trailing 12 months.
Which sector does the Allied company belong to?
The Allied sector is Healthcare.